Lenacapavir was approved for use in HIV-positive adults with multi-drug resistance by the European Union in August 2022 and ...

Gilead Sciences signs voluntary licensing agreement with six pharma firms to produce generic lenacapavir: Our Bureau, New Delhi Thursday, October 3, 2024, 11:30 Hrs [IST] US-based ...

Hetero has partnered with Gilead Sciences to manufacture and distribute the HIV drug lenacapavir in 120 low- and ...

Dr. Reddy's, Hetero, and Mylan partner with Gilead Sciences to manufacture generic lenacapavir for HIV prevention globally.

Gilead Sciences first launched lenacapavir under the brand name Sunlenca in the United States and European markets in 2022. It is a first-in-class HIV-1 capsid inhibitor ...

Hetero and Gilead have partnered to expand access to lenacapavir, a groundbreaking HIV treatment, in 120 low- and ...

Pharmaceutical firm Hetero has partnered with Gilead Sciences Ireland UC to manufacture and distribute the HIV treatment drug lenacapavir in 120 primarily low- and lower-middle-income countries. The ...

Medical leaders in India have expressed alarm over a drug alert issued by the country’s drug regulator that lists 50 products as “not of standard quality.” The list, issued by the Central Drugs ...

GlobalData’s report assesses the drugs in the Estrogen Receptor Beta pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

A call to remove a man from the Boy Scouts of America in Tamuning led to finding drugs and stolen goods from Home Depot, a magistrate’s complaint filed in Superior Court states. Joseph Bennett ...